Fred Rahbari from @EmoryUniversity on ADPKD. T2 in #MRI is best to visualize cysts (white) #renalimaging #kidneyimaging #NephroNet2018

Dr. Fervenza presenting MENTOR and RTX for MN. My take stays unchanged: it does matter if response is at 4 vs 18 months. And toxicity of CYC vs. RTX in ANCA trials was similar. I’ll keep using the Dutch CYC trial. With PLA2R monitoring, 3-4 mo Rx is usually enough #NephroNet2018

Kirk Campbell from @ISMMSKidney sharing his story on dendrin as a bad guy in #podocytopathies #NephroNet2018

Samir Parikh from @OhioStateMed #Nephrology making the case for repeat #kidneybiopsy in #lupus nephritis #NephroNet2018

Jim Tumlin on #uremic #pruritus. Kappa opioid receptor agonists might be better than back roller scratchers #NephroNet2018

Gerry Appel taking us back to the revised view of MPGN
#NephroNet2018

Biff Palmer on hyperkalemia: basolateral voltage mechanism to enhance K excretion after an oral load #NephroNet2018

@GlassockJ shares evolving concept that renin cleaves C3 convertase, suggesting that aliskiren might be a preferable #RAS blocker in IgA #nephropathy #NephroNet2018